These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28814926)

  • 21. Identifying residual transmission of lymphatic filariasis after mass drug administration: Comparing school-based versus community-based surveillance - American Samoa, 2016.
    Sheel M; Sheridan S; Gass K; Won K; Fuimaono S; Kirk M; Gonzales A; Hedtke SM; Graves PM; Lau CL
    PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006583. PubMed ID: 30011276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria.
    Pam DD; de Souza DK; D'Souza S; Opoku M; Sanda S; Nazaradden I; Anagbogu IN; Okoronkwo C; Davies E; Elhassan E; Molyneux DH; Bockarie MJ; Koudou BG
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006004. PubMed ID: 29020042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lymphatic filariasis transmission assessment survey in schools three years after stopping mass drug treatment with albendazole and ivermectin in the 7 endemic districts in Togo].
    Dorkenoo AM; Sodahlon YK; Bronzan RN; Yakpa K; Sossou E; Ouro-Medeli A; Teko M; Seim A; Mathieu E
    Bull Soc Pathol Exot; 2015 Aug; 108(3):181-7. PubMed ID: 25476256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of disease and infection of lymphatic filariasis in Northeastern Cambodia.
    Leang R; Socheat D; Bin B; Bunkea T; Odermatt P
    Trop Med Int Health; 2004 Oct; 9(10):1115-20. PubMed ID: 15482405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of repeated half-yearly diethylcarbamazine mass treatment on Wuchereria bancrofti infection and transmission in two East African communities with different levels of endemicity.
    Simonsen PE; Meyrowitsch DW; Mukoko DA; Pedersen EM; Malecela-Lazaro MN; Rwegoshora RT; Ouma JH; Masese N; Jaoko WG; Michael E
    Am J Trop Med Hyg; 2004 Jan; 70(1):63-71. PubMed ID: 14971700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interruption of lymphatic filariasis transmission in Manaus, a former focus of
    Martins M; Guimarães RCS; Fontes G
    Rev Panam Salud Publica; 2021; 45():e1. PubMed ID: 33488682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology of elephantiasis with special emphasis on podoconiosis in Ethiopia: A literature review.
    Yimer M; Hailu T; Mulu W; Abera B
    J Vector Borne Dis; 2015 Jun; 52(2):111-5. PubMed ID: 26119541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Burden of lymphatic filariasis morbidity in an area of low endemicity in Brazil.
    Netto MJ; Bonfim C; Brandão E; Aguiar-Santos AM; Medeiros Z
    Acta Trop; 2016 Nov; 163():54-60. PubMed ID: 27427218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular xenomonitoring as a post-MDA surveillance tool for global programme to eliminate lymphatic filariasis: Field validation in an evaluation unit in India.
    Subramanian S; Jambulingam P; Krishnamoorthy K; Sivagnaname N; Sadanandane C; Vasuki V; Palaniswamy C; Vijayakumar B; Srividya A; Raju HKK
    PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007862. PubMed ID: 31978060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of circulating parasite antigen in bancroftian filariasis by counterimmunoelectrophoresis.
    Weil GJ; Kumar H; Santhanam S; Sethumadhavan KV; Jain DC
    Am J Trop Med Hyg; 1986 May; 35(3):565-70. PubMed ID: 3518508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda.
    Luroni LT; Gabriel M; Tukahebwa E; Onapa AW; Tinkitina B; Tukesiga E; Nyaraga M; Auma AM; Habomugisha P; Byamukama E; Oguttu D; Katabarwa M; Unnasch TR
    PLoS One; 2017; 12(12):e0189306. PubMed ID: 29253862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators.
    Jambulingam P; Subramanian S; de Vlas SJ; Vinubala C; Stolk WA
    Parasit Vectors; 2016 Sep; 9(1):501. PubMed ID: 27624157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of sensitivity of immunochromatographic test (ICT) for lymphatic filariasis diagnosis in low prevalence settings: consequence in the monitoring and evaluation procedures.
    Gounoue-Kamkumo R; Nana-Djeunga HC; Bopda J; Akame J; Tarini A; Kamgno J
    BMC Infect Dis; 2015 Dec; 15():579. PubMed ID: 26700472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters.
    Wamae CN; Njenga SM; Ngugi BM; Mbui J; Njaanake HK
    Acta Trop; 2011 Sep; 120 Suppl 1():S33-8. PubMed ID: 20933491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic clinical manifestations related to Wuchereria bancrofti infection in a highly endemic area in Kenya.
    Njenga SM; Wamae CN; Njomo DW; Mwandawiro CS; Molyneux DH
    Trans R Soc Trop Med Hyg; 2007 May; 101(5):439-44. PubMed ID: 17145069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Filarial-specific IgG4 response correlates with active Wuchereria bancrofti infection.
    Kwan-Lim GE; Forsyth KP; Maizels RM
    J Immunol; 1990 Dec; 145(12):4298-305. PubMed ID: 2258618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of two tests for filarial antigenemia in areas in Sri Lanka and Indonesia with low-level persistence of lymphatic filariasis following mass drug administration.
    Yahathugoda TC; Supali T; Rao RU; Djuardi Y; Stefani D; Pical F; Fischer PU; Lloyd MM; Premaratne PH; Weerasooriya MV; Weil GJ
    Parasit Vectors; 2015 Jul; 8():369. PubMed ID: 26168919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The epidemiological delimitation of lymphatic filariasis in an endemic area of Brazil, 41 years after the first recorded case.
    Medeiros Z; Bonfim C; Alves A; Oliveira C; Netto MJ; Aguiar-Santos AM
    Ann Trop Med Parasitol; 2008 Sep; 102(6):509-19. PubMed ID: 18782490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of six rounds of single-dose mass administration of diethylcarbamazine or ivermectin on the transmission of Wuchereria bancrofti by Culex quinquefasciatus and its implications for lymphatic filariasis elimination programmes.
    Ramaiah KD; Das PK; Vanamail P; Pani SP
    Trop Med Int Health; 2003 Dec; 8(12):1082-92. PubMed ID: 14641843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A surveillance system for lymphatic filariasis after its elimination in Sri Lanka.
    Rahman MA; Yahathugoda TC; Tojo B; Premaratne P; Nagaoka F; Takagi H; Kannathasan S; Murugananthan A; Weerasooriya MV; Itoh M
    Parasitol Int; 2019 Feb; 68(1):73-78. PubMed ID: 30308253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.